US6083922A
(en)
*
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
US6076520A
(en)
*
|
1997-05-12 |
2000-06-20 |
Cooper; Emily L. |
Device for nasal therapeutic inhalation
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
JP2002532430A
(ja)
*
|
1998-12-17 |
2002-10-02 |
パソゲネシス コーポレイション |
エアゾール化抗生物質を用いる重篤な慢性気管支炎(気管支拡張症)の処置方法
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
US6576224B1
(en)
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
DE60140121D1
(de)
|
2000-02-11 |
2009-11-19 |
Respironics Respiratory Drug D |
Wirkstoffabgabevorrichtung
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
AU6124601A
(en)
|
2000-05-10 |
2001-11-20 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7214364B2
(en)
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
ES2360692T3
(es)
*
|
2000-12-27 |
2011-06-08 |
Gilead Sciences, Inc. |
Aztreonam inhalable para tratamiento y prevención de infecciones bacterianas pulmonares.
|
EP1598059A1
(de)
|
2001-05-18 |
2005-11-23 |
Chiron Corporation |
Verfahren und Formulierungen von Dosierungseinheiten für die Verabreichung von Aminoglykosidantibiotika als Inhalationverfahren und Formulierungen von Dosierungseinheiten für die Verabreichung von Aminoglykosidantibiotika als Inhalation
|
CA2447600C
(en)
*
|
2001-05-18 |
2015-10-20 |
Chiron Corporation |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
TR200401980T4
(tr)
*
|
2001-07-02 |
2004-09-21 |
Chiesi Farmaceutici S.P.A. |
Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
|
US20040022740A1
(en)
*
|
2001-07-10 |
2004-02-05 |
Baker William R. |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
JP2005514393A
(ja)
*
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
アミノグリコシドの肺への供給
|
PT3494995T
(pt)
*
|
2002-03-01 |
2020-03-30 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
US7334580B2
(en)
*
|
2002-05-07 |
2008-02-26 |
Smaldone Gerald C |
Methods, devices and formulations for targeted endobronchial therapy
|
WO2003101390A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Childrens Hospital And Regional Medical Center |
Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function
|
US6966649B2
(en)
*
|
2002-08-12 |
2005-11-22 |
John H Shadduck |
Adaptive optic lens system and method of use
|
US20040045546A1
(en)
*
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
AU2004281532B2
(en)
*
|
2003-10-15 |
2010-03-18 |
Pari Pharma Gmbh |
Liquid preparation containing tobramycin
|
CA2564546C
(en)
*
|
2004-05-17 |
2013-02-26 |
Corus Pharma, Inc. |
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
|
PL1765288T3
(pl)
*
|
2004-06-18 |
2013-04-30 |
Novartis Ag |
Preparaty tobramycyny do leczenia zakażań oskrzeli
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
US8524735B2
(en)
*
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US7838532B2
(en)
*
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
AU2013206401B2
(en)
*
|
2005-09-29 |
2016-06-23 |
Novartis Ag |
Antibiotic formulations, unit doses, kits, and methods
|
EP1928410A2
(de)
|
2005-09-29 |
2008-06-11 |
Nektar Therapeutics |
Antibiotische formulierungen, einheitsdosen, kits und verfahren
|
PL1962805T3
(pl)
|
2005-12-08 |
2017-01-31 |
Insmed Incorporated |
Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
|
US8337814B2
(en)
*
|
2005-12-15 |
2012-12-25 |
Topical Sinus Therapeutics, Inc. |
Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions
|
ES2668554T3
(es)
*
|
2006-04-06 |
2018-05-18 |
Insmed Incorporated |
Métodos para la encapsulación liposomal inducida por coacervación y sus formulaciones
|
US9539303B2
(en)
*
|
2006-04-24 |
2017-01-10 |
Celgene Corporation |
Treatment of Ras-expressing tumors
|
PE20080329A1
(es)
*
|
2006-06-07 |
2008-04-09 |
Wyeth Corp |
Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol
|
US20070286818A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via an aerosol drug
|
WO2007145866A1
(en)
*
|
2006-06-07 |
2007-12-21 |
Wyeth |
Treating cystic fibrosis with antibiotics via a swirler delivery
|
US20070286817A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via a swirler delivery
|
US8957027B2
(en)
*
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
KR20090077914A
(ko)
|
2006-09-11 |
2009-07-16 |
쿠리스 인코퍼레이션 |
항증식제로서의 다작용성 소분자
|
MX2009003002A
(es)
*
|
2006-09-19 |
2009-06-01 |
Discovery Lab Inc |
Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
|
JP2008199905A
(ja)
*
|
2007-02-16 |
2008-09-04 |
Snow Brand Milk Prod Co Ltd |
乳酸菌生残性向上剤
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
*
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
KR20100060004A
(ko)
*
|
2007-09-25 |
2010-06-04 |
노파르티스 아게 |
에어로졸화된 반코마이신과 같은 의약에 의한 폐 질병의 치료
|
US8834930B2
(en)
*
|
2008-05-15 |
2014-09-16 |
Novartis Ag |
Pulmonary delivery of a fluoroquinolone
|
US8815838B2
(en)
|
2008-10-07 |
2014-08-26 |
David C. Griffith |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
PL2346509T3
(pl)
*
|
2008-10-07 |
2021-03-08 |
Horizon Orphan Llc |
Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
|
KR101411889B1
(ko)
|
2009-02-27 |
2014-06-27 |
이난타 파마슈티칼스, 인코포레이티드 |
C형 간염 바이러스 억제제
|
US20120018526A1
(en)
*
|
2009-03-20 |
2012-01-26 |
Livia Tiba |
Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
|
DK2445502T4
(da)
|
2009-06-25 |
2022-11-28 |
Alkermes Pharma Ireland Ltd |
Heterocycliske forbindelser til behandling af neurologiske og psykologiske lidelser
|
MX353288B
(es)
|
2009-09-04 |
2018-01-08 |
Raptor Pharmaceuticals Inc |
Uso de levofloxacina aerosolizada para el tratamiento de fibrosis quistica.
|
CA2784207C
(en)
|
2009-12-14 |
2018-06-05 |
Chiesi Farmaceutici S.P.A. |
Antibiotic microparticles for inhalation
|
AU2010339689B2
(en)
|
2010-01-07 |
2015-02-19 |
Alkermes Pharma Ireland Limited |
Quaternary ammonium salt prodrugs
|
EP2388008A1
(de)
|
2010-05-14 |
2011-11-23 |
Combino Pharm, S.L. |
Stabile, konservierungsmittelfreie, wässrige Formulierung zur Verabreichung durch Aerosolisierung enthaltend Tobramycin
|
CA2802733C
(en)
|
2010-06-24 |
2017-11-21 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
RU2597842C2
(ru)
|
2010-07-12 |
2016-09-20 |
Кселлия Фармасьютикалз Апс |
Лечение легочных инфекций с помощью введения тобрамицина путем аэролизации
|
CA2822447C
(en)
|
2010-12-23 |
2018-05-01 |
Alkermes Pharma Ireland Limited |
Multi-api loading prodrugs
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
ES2733128T3
(es)
|
2011-04-01 |
2019-11-27 |
Curis Inc |
Inhibidor de fosfoinosítido 3-quinasa con un resto de unión a cinc
|
US8826904B2
(en)
|
2011-07-12 |
2014-09-09 |
Cardeas Pharma Corporation |
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
|
BR112014000275A2
(pt)
|
2011-07-12 |
2017-04-18 |
Cardeas Pharma Inc |
formulações aperfeiçoadas de combinações de aminoglicosídeo e fosfomicina e métodos e sistemas para o tratamento de pneumonia associada à ventilação mecânica (pavm) e traqueobronquite associada à ventilação mecânica (vat)
|
PL2567691T3
(pl)
|
2011-09-12 |
2015-05-29 |
Meiji Seika Pharma Co Ltd |
Kompozycje wodne obejmujące arbekacynę
|
AU2012351805B2
(en)
|
2011-12-15 |
2016-04-21 |
Alkermes Pharma Ireland Limited |
Samidorphan (ALKS 33) in combination with opioid agonists
|
US8969337B2
(en)
|
2011-12-15 |
2015-03-03 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
GB201208080D0
(en)
|
2012-05-09 |
2012-06-20 |
Norton Healthcare Ltd |
Tobramycin formulation
|
JP6402097B2
(ja)
|
2012-05-21 |
2018-10-10 |
インスメッド インコーポレイテッド |
肺感染症を処置するためのシステム
|
CN102949379B
(zh)
*
|
2012-11-14 |
2014-11-05 |
中山大学 |
硫酸奈替米星吸入粉雾剂及其制备方法
|
ES2743039T3
(es)
|
2012-11-29 |
2020-02-18 |
Insmed Inc |
Formulaciones de vancomicina estabilizada
|
WO2014160478A1
(en)
|
2013-03-13 |
2014-10-02 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
KR20160138494A
(ko)
|
2014-03-31 |
2016-12-05 |
데비오팜 인터네셔날 에스 에이 |
Fgfr 융합물
|
US10238675B2
(en)
|
2014-05-15 |
2019-03-26 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
EP4112071A1
(de)
|
2014-08-26 |
2023-01-04 |
HSF Pharmaceuticals |
Neuartige immunisierungsmittel und verfahren zur verwendung
|
CN107106546A
(zh)
|
2014-10-06 |
2017-08-29 |
弗拉特利发现实验室有限责任公司 |
三唑并吡啶化合物和用于治疗囊性纤维化的方法
|
US11291780B2
(en)
*
|
2014-12-04 |
2022-04-05 |
Vyaire Medical Consumables Llc |
Breath-actuated nebulizer for medicine inhalation
|
CN105616345B
(zh)
*
|
2016-03-01 |
2018-08-21 |
上海方予健康医药科技有限公司 |
一种妥布霉素吸入组合物及其制备方法和用途
|
JP6904970B2
(ja)
|
2016-03-07 |
2021-07-21 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
B型肝炎抗ウイルス剤
|
US11597708B2
(en)
|
2016-09-16 |
2023-03-07 |
Hsf Pharmaceuticals Sa |
Inhibitors of heat shock factors and uses thereof
|
US20200283829A1
(en)
*
|
2017-09-29 |
2020-09-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of developing pulmonary colonization/infection by pseudomonas aeruginosa
|
EP3762024A1
(de)
|
2018-03-08 |
2021-01-13 |
HSF Pharmaceuticals |
Lokalisierte aktivierung herpesvirus-vektorierter impfstoffe als virusreplikationsbooster
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
JP2021523269A
(ja)
|
2018-05-10 |
2021-09-02 |
シーアイエス ファーマ アクツィエンゲゼルシャフトCIS Pharma AG |
複数の活性剤分子を含む生体適合コポリマー
|
BR112021004371A2
(pt)
|
2018-09-11 |
2021-05-25 |
Curis Inc. |
terapia em combinação com um inibidor de fosfoinositídeo 3-quinase com uma porção de ligação a zinco
|
US10865211B2
(en)
|
2018-09-21 |
2020-12-15 |
Enanta Pharmaceuticals, Inc. |
Functionalized heterocycles as antiviral agents
|
EP3653716A1
(de)
|
2018-11-19 |
2020-05-20 |
HSF Pharmaceuticals |
Replikationskompetente gesteuerte alpha-herpesvirus-virusvektoren und verwendungen davon
|
GB2565941A
(en)
*
|
2018-11-27 |
2019-02-27 |
Norton Healthcare Ltd |
A process for preparing a formulation
|
EP4051320A1
(de)
|
2019-10-30 |
2022-09-07 |
CIS Pharma AG |
Biokompatible polymere arzneimittelträger zur abgabe von wirkstoffen
|
WO2021214279A1
(en)
|
2020-04-24 |
2021-10-28 |
Hsf Pharmaceuticals |
Replication-competent controlled herpesviruses expressing a sars cov-2 antigen
|
WO2021262799A1
(en)
|
2020-06-23 |
2021-12-30 |
Flagship Pioneering, Inc. |
Anti-viral compounds and methods of using same
|
CN116348477A
(zh)
|
2020-07-20 |
2023-06-27 |
英安塔制药有限公司 |
作为抗病毒剂的功能化肽
|
EP4001279A1
(de)
|
2020-11-23 |
2022-05-25 |
Enanta Pharmaceuticals, Inc. |
Von spiropyrrolidin abgeleitete neue antivirale mittel
|
WO2023006993A1
(en)
|
2021-07-30 |
2023-02-02 |
Atmosr |
Fused amino pyridine or pyrimidine derivatives for the treatment of congenital central hypoventilation syndrome
|
CN114177140A
(zh)
*
|
2021-12-10 |
2022-03-15 |
卓和药业集团股份有限公司 |
一种硫酸奈替米星气雾剂
|